Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Миокардиты у детей

Список литературы

  1. Dasgupta S, Iannucci G, Mao C, Clabby M, Oster ME. Myocarditis in the pediatric population: A review // Congenit Heart Dis. - 2019 Sep. -Vol.14 (5). -P. 868-877. doi: 10.1111/chd.12835.
  2. Sagar S, Liu PP, Cooper LT Jr. Myocarditis // Lancet. -2012 Feb. -Vol.379 (9817). -P. 738–747. doi: 10.1016/S0140-6736(11)60648-X
  3. Caforio AL, Pankuweit S, Arbustini E, Basso C, et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases // European Heart Journal. -2013 Sep. -Vol.34 (33). -P. 2636–2648. doi: 10.1093/eurheartj/eht210
  4. Canter CE, Simpson KP. Diagnosis and Treatment of Myocarditis in Children in the Current Era // Circulation. -2014 Jan. Vol.129(1). -P.115–128.
  5. Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions // Nat Rev Cardiol. -2021 Mar. -Vol.18 (3). -P. 169-193.
  6. Rroku A, Kottwitz J, Heidecker B. Update on myocarditis – what we know so far and where we may be heading // European Heart Journal. Acute Cardiovascular Care. -2021 April. -Vol.10 - Issue 4. -P. 455–467. doi.org/10.1177/2048872620910109
  7. Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis // Heart. -2012. Vol.98. -P. 835–840. doi: 10.1136/heartjnl-2012-301686
  8. Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes // Circ Res. -2017 -Vol.121. -P. 803–818. doi.org/10.1161/CIRCRESAHA.117.310221
  9. Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis-diagnosis, treatment options, and current controversies // Nat Rev Cardiol. -2015. -Vol.12. -P. 670–680. doi: 10.1038/nrcardio.2015.108
  10. Karatolios K, Pankuweit S, Maisch B. Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy // Curr Treat Options Cardiovasc Med. -2007 Dec. -Vol.9 (6). -P. 473-81.
  11. Van Linthout S, Tschöpe C. Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy //Curr Opin Cardiol. -2018 May. -Vol.33(3). -P. 325-333. doi: 10.1097/HCO.0000000000000515
  12. Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D. Clinical characteristics of severe neonatal enterovirus infection: a systematic review // BMC Pediatr. -2021 Mar 15. -Vol. 21 (1). -P. 127. doi: 10.1186/s12887-021-02599-y.
  13. Maki S, Aizawa Y, Ito Y, Suda M, Saitoh A. Acute heart failure due to dilated cardiomyopathy exacerbated by systemic parechovirus A1 infection in an infant // Int J Infect Dis. -2021 Mar. -Vol.104. -P. 273-275. doi: 10.1016/j.ijid.2021.01.021
  14. Verdonschot J, Hazebroek M, Merken J, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature // Eur J Heart Fail 2016. -Vol. 18 (12). -P. 1430–1441. doi: 10.1002/ejhf.665
  15. Bejiqi R, Retkoceri R, Maloku A, Mustafa A, et al. The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature // Open Access Maced J Med Sci. -2019 Jan 4. -Vol.7(1). -P. 162-173. doi: 10.3889/oamjms.2019.010
  16. Molina KM, Garcia X, Denfield SW, Fan Y, Morrow WR, TowbinJA, Frazier EA, Nelson DP. Parvovirus B19 myocarditis causes significant morbidity and mortality in children // Pediatr Cardiol. -2013. -Vol.34. -P. 390–397. doi: 10.1007/s00246-012-0468-4
  17. McMurray JC, May JW, Cunningham MW, Jones OY. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment // Front Pediatr. -2020 Dec 16. -Vol.8. -P. 626182. doi: 10.3389/fped.2020.626182
  18. Dhar D, Dey T, Samim MM, Padmanabha H, Chatterjee A, Naznin P, Chandra SR, Mallesh K, Shah R, Siddiqui S, Pratik K, Ameya P, Abhishek G. Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis // Pediatr Res. -2021 May. -Vol.18. -P. 1–16.
  19. Bellissima BL, Vara A, Helsby N, Garavan F, Tingle MD. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort // Psychiatry Res. -2021 May. -Vol.299. -P. 113873. DOI: 10.1016/j.psychres.2021.113873
  20. Curigliano G, Cardinale D, Suter T, Plataniotis G, et al. ESMO Guidelines Working Group. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines // Ann Oncol. -2012 Oct. -23 Suppl 7. -vii155-66. doi: 10.1093/annonc/mds293
  21. Curigliano G, Lenihan D, Fradley M, et al. ESMO Guidelines Committee. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations // Ann Oncol. -2020 Feb. Vol.31(2). -P. 171-190.
  22. Gauntt C. Coxsackievirus experimental heart diseases // Front. Biosci. -2003. -Vol. 8 (5). -e23-35. Doi: 10.2741/928
  23. Engler R.J.M.et al. A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination // PLOS ONE / ed. Horwitz M.S. -2015. -Vol.10 (3). -e0118283. doi.org/10.1371/journal.pone.0118283
  24. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link // Cardiovasc. Res. – 2003. – Vol.60 (1). – P. 5–10. doi: 10.1016/s0008-6363(03)00437-1
  25. Calabrese F., Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects // Cardiovasc. Res. – 2003. – Vol. 60 (1). – P. 11–25. doi: 10.1016/s0008-6363(03)00475-9
  26. Baggio С, Gagno G, Porcari A .et al. Myocarditis: Which Role for Genetics? // Curr Cardiol Rep. -2021. -Vol.23 (6). -P. 58-63. doi: 10.1007/s11886-021-01492-5
  27. Artico J, Merlo M, Delcaro G, .et al. Lymphocytic myocarditis: a genetically predisposed disease? // J Am Coll Cardiol. -2020. -Vol.75. -P. 3098–3100. doi: 10.1016/j.jacc.2020.04.048
  28. Ammirati E, Frigerio M, Adler ED, et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document // Circ Heart Fail. -2020 Nov. -Vol. 13(11). -e007405. doi.org/10.1161/CIRCHEARTFAILURE.120.007405
  29. Caforio ALP, Malipiero G, Marcolongo R, Iliceto S. Myocarditis: A Clinical Overview // Curr Cardiol Rep.- 2017. -Vol. 19. -P. 63. doi: 10.1007/s11886-017-0870-x
  30. Chang Y-J, Hsiao H-J, Hsia S-H, et al. Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis // PLoS ONE. -2019. -Vol.14(3). -e0214087. doi.org/10.1371/journal.pone.0214087
  31. Matsuura H, Ichida F, Saji T, et al. Clinical features of acute and fulminant myocar-ditis in children // Circ J. – 2016. -Vol.80 (11). -P. 2362–2368. doi: 10.1253/circj.CJ-16-0234
  32. Arola A, Pikkarainen E .et al. Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland // J Am Heart Assoc. -2017 Nov. -Vol.6(11). -e005306. doi: 10.1161/JAHA.116.005306
  33. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States // N Engl J Med. -2003 Apr. -Vol.348. -P. 1647-1655. DOI: 10.1056/NEJMoa021715
  34. Myocarditis Foundation . Myocarditis in children: incidence, clinical characteristics and outcomes // -Published July 29. 2020. Accessed November 15, 2020. https://www.myocarditisfoundation.org/myocarditis-in-children-incidence-clinical-characteristics-and-outcomes/.
  35. Butts RJ, Boyle GJ, Deshpande SR, et al. Characteristics of clinically diagnosed pediatric myocarditis in a contemporary multicenter cohort // Pediatr Cardiol. -2017. -Vol.38(6). -P. 1175–1182. doi: 10.1007/s00246-017-1638-1
  36. Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D(2012) Demographics, trends, and outcomes in pediatric acutemyocarditis in the United States, 2006 to 2011 // Circ Cardiovasc Qual Outcomes. -2012 Sep. -Vol.5(5). -P. 622–627. doi: 10.1161/CIRCOUTCOMES.112.965749
  37. Klugman D, Berger JT, Sable CA, He J, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis // Pediatr Cardiol. -2010. -Vol.31. -P. 222–228. doi: 10.1007/s00246-009-9589-9
  38. Durani Y, Giordano K, Goudie BW. Myocarditis and pericarditis in children // Pediatr Clin North Am. -2010. -Vol.57. -P. 1281-1303.
  39. Neagu O, Rodríguez AF, Callon D, Andréoletti L, Cohen MC. Myocarditis Presenting as Sudden Death in Infants and Children: A Single Centre Analysis by ESGFOR Study Group // Pediatr Dev Pathol. -2021 Apr. -Vol.19. -P. 10935266211007262. doi: 10.1016/j.pcl.2010.09.012
  40. Meyer L, Stubbs B, Fahrenbruch C, Maeda C, et al. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review // Circulation. -2012 Sep 11. -Vol.126(11). -P. 1363-72.
  41. Nugent AW, Daubeney PE, Chondros P, et al. National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia // N Engl J Med. -2003 Apr 24. -Vol.348(17). -P. 1639-46. Accessed January 14, 2020. doi: 10.1161/CIRCULATIONAHA.111.076810
  42. Vetter VL, Covington TM, Dugan PN, Haley DM, MPH, Dykstra H, Overpeck M et al. Cardiovascular deaths in children: General overview from the National Center for the Review and Prevention of Child Deaths // Am Heart J. -2015. -Vol.169(3). -P. 426-437.
  43. Lv J, Han B, Wang C, Wang J, Jiang D, Zhao L, Yi Y, Zhang J. The Clinical Features of Children With Acute Fulminant Myocarditis and the Diagnostic and Follow-Up Value of Cardiovascular Magnetic Resonance // Front Pediatr. -2019 Oct. -Vol.7. -P. 388. doi: 10.3389/fped.2019.00388
  44. Winkel BG, Risgaard B, Sadjadieh G, et al. Sudden cardiac death in children (1–18 years): symptoms and causes of death in a nationwide setting // Eur Heart J 2014. -Vol.35. -P. 868–875. doi: 10.1093/eurheartj/eht509
  45. Bohm P, Scharhag J, Meyer T. Data from a nationwide registry on sports-related sudden cardiac deaths in Germany // Eur J Prev Cardiol. -2016 Apr. -Vol.23(6). -P. 649-56. doi: 10.1177/2047487315594087
  46. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis // J Am Coll Cardiol. -1991 Dec. -Vol.18(7). -P. 1617-26. doi: 10.1016/0735-1097(91)90493-s
  47. Ginsberg F, Parrillo JE. Fulminant myocarditis // Crit Care Clin. -2013. -Vol.29. -P. 465–483. doi: 10.1016/j.ccc.2013.03.004
  48. Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, Merlo M. Myocarditis in Clinical Practice // Mayo Clin Proc. -2016 Sep. -Vol.91(9). -P. 1256-66. doi: 10.1016/j.mayocp.2016.05.013
  49. Abe T, Tsuda E, Miyazaki A, et al. Clinical characteristics and long-term outcome of acute myocarditis in children // Heart Vessels. -2013. -Vol.28(5). -P. 632–8. doi: 10.1007/s00380-012-0296-8
  50. Degener F, Opgen-Rhein B, Bo¨hne M, et al. Four-Year Experience of the German Multicenter Registry for Pediatric Patients with Suspected Myocarditis: MYKKE // In: 50th Annual Meeting of the German Society for Pediatric Cardiology (DGPK). -2018. -Vol 66. Georg Thieme Verlag KG. doi:10.1055/s-0038-1628324
  51. Niu L, An X-J, Tian J, et al. 124 cases of clinical analysis of children with viral myocarditis // Eur Rev Med Pharmacol Sci. -2015. -Vol.19 (15). -P. 2856–9.
  52. Price S, Bodys A, Celinska A, et al. Interlibrary Loan The value of chosen diagnostic tools in evaluating myocarditis in children and adolescents // Pediatr Pol J Paediatr. -2018. -Vol. 93(5). -P. 389–95.
  53. Rodriguez-Gonzalez M, Sanchez-Codez MI, Lubian-Gutierrez M, et al. Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study // World J Clin Cases. -2019. -Vol.7(5). -P. 548–61. doi: 10.12998/wjcc.v7.i5.548
  54. Suthar D, Dodd DA, Godown J. Identifying Non-invasive Tools to Distinguish Acute Myocarditis from Dilated Cardiomyopathy in Children // Pediatr Cardiol. -2018. -Vol.39(6). -P. 1134–8. doi: 10.1007/s00246-018-1867-y
  55. Wu HP, Lin MJ, Yang WC, et al. Predictors of Extracorporeal Membrane Oxygenation Support for Children with Acute Myocarditis // Biomed Res Int. -2017 May. -Vol. 2017. -P. 8. doi.org/10.1155/2017/2510695
  56. Freund MW, Kleinveld G, Krediet TG, et al. Prognosis for neonates with entero-virus myocarditis // Arch Dis Child Fetal Neonatal Ed. -2010 May. -Vol.95(3). -F206–12. doi: 10.1136/adc.2009.165183.
  57. Putschoegl A, Auerbach S. Diagnosis, Evaluation, and Treatment of Myocarditis in Children // Pediatr Clin N Am. -2020 Oct. -Vol.67 (5). -P. 855–874. doi: 10.1016/j.pcl.2020.06.013
  58. Tunuguntla H, Jeewa A, Denfield SW. Acute Myocarditis and Pericarditis in Children // Pediatr Rev. -2019. -Vol.40(1). -P. 14-25. doi: 10.1542/pir.2018-0044
  59. Levine MC, Klugman D, Teach SJ. Update on myocarditis in children // Curr Opin Pediatr. -2010. -Vol.22. -P. 278–283. doi: 10.1097/MOP.0b013e32833924d2
  60. Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation // Pediatrics. – 2007. – Vol.120(6). – P. 1278-1285. doi: 10.1542/peds.2007-1073
  61. Schubert S, Opgen-Rhein B, Boehne M, Weigelt A, et al. MYKKE consortium. Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry "MYKKE" // Pediatr Transplant. -2019 Nov. -Vol.23(7). -e13548. doi.org/10.1111/petr.13548
  62. Howard А., Hasan A., Brownlee J., Mehmood N., Ali M., et al. Pediatric Myocarditis Protocol: An Algorithm for Early Identifcation and Management with Retrospective Analysis for Validation // Pediatric Cardiology. – 2020 Feb. -Vol.41. -P. 316–326. doi: 10.1007/s00246-019-02258-1
  63. Kantor, P. F., Lougheed, J., Dancea, A., et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines // Canadian Journal of Cardiology. – 2013. -Vol.29(12). -P. 1535-1552. doi: 10.1016/j.cjca.2013.08.008
  64. Bergmann KR, Kharbanda A, Haveman L Myocarditis and Pericarditis In The Pediatric Patient: Validated Management Strategies // Pediatr Emerg Med Pract. -2015 Jul. -Vol.12(7). -P. 1-22; quiz 23.
  65. Kern J, Modi R, Atalay MK, Kochilas LK. Clinical myocarditis masquerading as acute coronary syndrome // J Pediatr. -2009 Apr. -Vol.154(4). -P. 612-5. doi: 10.1016/j.jpeds.2008.10.018
  66. Cooper LT Jr.Ventricular Arrhythmias and Sudden Cardiac Death in Lymphocytic Myocarditis // J Am Coll Cardiol. -2020 Mar 10. -Vol.75(9). -P. 1058-1060. doi: 10.1016/j.jacc.2020.01.032
  67. Ling N, Li CL, Wang ZZ, Zhang HN, Xu H, An XJ. Heart rate variability in children with myocarditis presenting with ventricular arrhythmias // Eur Rev Med Pharmacol Sci. -2018 Feb. -Vol. 22(4). -P. 1102-1105. doi: 10.26355/eurrev_201802_14397
  68. Школьникова М.А, Алексеева Е.И. Клинические рекомендации по детской кардиологии и ревматологии // М. -2011. – c. 512.
  69. Brady WJ, Ferguson JD, Ullman EA, Perron AD. Myocarditis: emergency department recognition and management // Emerg Med Clin North Am. -2004 Nov. -Vol.22(4). -P. 865-85. doi: 10.1016/j.emc.2004.05.010
  70. Балыкова Л.А., Краснопольская А.В., Власова Е.А. Миокардиты у детей: клиническая картина, диагностика и лечение // Педиатрическая фармакология. -2020. -№17(2). - С. 137-147.
  71. Patel M.S.,Berg A.M., Vincent R.N., Mahle W.T. Serum parameters and echocardiographic predictors of death or need for transplant in newborns, children, and young adults with heart failure // Am J Cardiol. -2010. -Vol.105. -P. 1798-1801. doi: 10.1016/j.amjcard.2010.01.357
  72. Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes // J Am Coll Cardiol. – 2017. -Vol.70. -P. 2363–2375.
  73. Lippi G, Salvagno GL, Guidi GC. Cardiac troponins in pediatric myocarditis // Pediatrics. -2008. -Vol.121(4). -P. 864. doi: 10.1542/peds.2008-0031
  74. Kühl U., Pauschinger M., et.al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction // Circulation. -2005 Feb 22. -Vol.111(7). -P. 887-93. doi.org/10.1161/01.CIR.0000155616.07901.35
  75. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version // Circ. J. Off. J. Jpn. Circ. Soc. -2011. -Vol.75 (3). -P. 734–743. doi: 10.1253/circj.cj-88-0008
  76. McNamara D M. Heart Failure as a Consequence of Viral and Nonviral Myocarditis Heart Failure: A Companion to Braunwald's Heart Disease // Elsevier. -2020. -Vol.28. -P. 376-384.e3
  77. Vigneswaran TV, Brown JR, Breuer J, Burch M. Parvovirus B19 myocarditis in children: an observational study // Arch Dis Child. -2016 Feb. -Vol.101(2). -P. 177-80. doi: 10.1136/archdischild-2014-308080
  78. Tuthar D, Dodd DA, Godown J. Identifying Non-invasive Tools to Distinguish Acute Myocarditis from Dilated Cardiomyopathy in Children // PediatrCardiol. -2018 .-Vol. 39(6). -P. 1134–8.
  79. Foerster SR, Canter CE, Cinar A, et al Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood // Circ Heart Fail. – 2010. -Vol.3. -P. 689–697. doi: 10.1161/CIRCHEARTFAILURE.109.902833
  80. Felker GM, Boehmer JP, Hruban RH et al Echocardiographic fndings in fulminant and acute myocarditis // J Am Coll Cardiol. -2000. -Vol. 36(1). -P. 227-32. doi: 10.1016/s0735-1097(00)00690-2.
  81. Gursu HA, Cetin AE, Kibar AE, et al The assessment of treatment outcomes in patients with acute viral myocarditis by speckle tracking and tissue Doppler methods // Echocardiography. -2019. -Vol.36. -P. 1666–1674. doi: 10.1111/echo.14449.
  82. Wisotzkey BL, Soriano, BD, Albers, EL, et al Diagnostic role of strain imaging in atypical myocarditis by echocardiography and cardiac MRI // Pediatr Radiol. -2018. -Vol.48. -P.835–842. doi: 10.1007/s00247-017-4061-0
  83. Khoo NS, Smallhorn, JF, Atallah, J, et al Altered left ventricular tissue velocities, deformation and twist in children and young adults with acute myocarditis and normal ejection fraction // J Am Soc Echocardiogr. -2012. -Vol.25. -P. 294–303. doi: 10.1016/j.echo.2011.10.010
  84. Banka P, Robinson JD, Uppu SC, Harris MA, et al. Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study // Journal of cardiovascular magnetic resonance: official journal of the Society for Cardiovascular Magnetic Resonance. -2015. -Vol.17. -P. 96. doi: 10.1186/s12968-015-0201-6.
  85. Friedrich MG, Sechtem U, Schulz-Menger J, et al. ; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper // J Am Coll Cardiol. -2009. -Vol.53. -P. 1475–1487. doi: 10.1016/j.jacc.2009.02.007
  86. Pan JA, Lee YJ, Salerno M. Diagnostic performance of extracellular volume, native T1, and T2 mapping versus lake louise criteria by cardiac magnetic resonance for detection of acute myocarditis: a meta-analysis // Circ Cardiovasc Imaging. -2018. -Vol.11. -e007598. doi: 10.1161/CIRCIMAGING.118.007598
  87. Wei S, Fu J, Chen L, Yu S. Performance of Cardiac Magnetic Resonance Imaging for Diagnosis of Myocarditis Compared with Endomyocardial Biopsy: A Meta-Analysis // Med Sci Monit. -2017. -Vol.23. -P. 3687-3696. doi: 10.12659/msm.902155
  88. Kotanidis CP, Bazmpani MA, Haidich AB, Karvounis C, Antoniades C, Karamitsos TD. Diagnostic accuracy of cardiovascular magnetic resonance in acute myocarditis: A Systematic Review and Meta-Analysis // J Am Coll Cardiol Img. -2018. -Vol.11(11). -P. 1583–90. doi: 10.1016/j.jcmg.2017.12.008
  89. Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations // J Am Coll Cardiol. -2018. -Vol.72. -P. 3158–3176.
  90. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) // J Cardiovasc Magn Reson. -2017. -Vol.19(1). -P. 75.
  91. Cornicelli M.D., Rigsby, C.K., Rychlik, K. et al. Diagnostic performance of cardiovascular magnetic resonance native T1 and T2 mapping in pediatric patients with acute myocarditis // J Cardiovasc Magn Reson. -2019. -Vol.21 (1). -P. 40. doi: 10.1186/s12968-019-0550-7
  92. Luetkens JA, Faron A, Isaak A, Dabir D, Kuetting D, et al. Comparison of original and 2018 lake louise criteria for diagnosis of acute myocarditis: results of a validation cohort // Radiology: Cardiothoracic Imaging. -2019. -Vol.1. -e190010. doi.org/10.1148/ryct.2019190010
  93. Francone M, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis // JACC Cardiovasc. Imaging. -2014. -Vol.7. -P. 254–263. doi: 10.1016/j.jcmg.2013.10.011
  94. Małek ŁA, Kamińska H, Barczuk-Falęcka M, et al. Children With Acute Myocarditis Often Have Persistent Subclinical Changes as Revealed by Cardiac Magnetic Resonance // J Magn Reson Imaging. -2020 Aug. -Vol.52(2). -P. 488-496.
  95. Aquaro GD, Ghebru Habtemicael Y, Camastra G, Monti L, Dellegrottaglie S, Moro C, Lanzillo C, Scatteia A, Di Roma M, Pontone G, et al.; “Cardiac Magnetic Resonance” Working Group of the Italian Society of Cardiology. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis // J Am Coll Cardiol. -2019. -Vol.74. -P. 2439–2448.
  96. Gräni C, Eichhorn C, Bière L, Murthy VL, Agarwal V, Kaneko K, Cuddy S, Aghayev A, Steigner M, Blankstein R, et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis // J Am Coll Cardiol. -2017. -Vol.70. -P. 1964–1976. DOI: 10.1016/j.jacc.2017.08.050
  97. Berg J, et al. Cardiac magnetic resonance imaging in myocarditis reveals persistent disease activity despite normalization of cardiac enzymes and inflammatory parameters at 3-month follow-up //Circ. Heart. -2017. -Vol.10. -e004262. doi: 10.1161/CIRCHEARTFAILURE.117.004262
  98. Rangamani S, Varghese J, Li L, Harvey L, et al. Safety of cardiac magnetic resonance and contrast angiography for neonates and small infants: a 10-year single-institution experience // Pediatr Radiol. -2012 Nov. -Vol.42(11). -P. 1339-46. DOI:10.1007/s00247-012-2452-9
  99. Jain R, Petrillo-Albarano T, Parks WJ,. et al. Efficacy and safety of deep sedation by non-anesthesiologists for cardiac MRI in children // Pediatr Radiol. -2013 Mar. -Vol.43(5). -P. 605-11. doi: 10.1007/s00247-012-2566-0
  100. Schmitz A, Weiss M, Kellenberger C, O'Gorman Tuura R, et al. Sedation for magnetic resonance imaging using propofol with or without ketamine at induction in pediatrics-A prospective randomized double-blinded study // Paediatr Anaesth. -2018 Mar. -Vol.28(3). -P. 264-274. doi: 10.1111/pan.13315
  101. Bussani R, Silvestri F, Perkan A, et al. Endomyocardial Biopsy. 2019 May 18. In: Sinagra G, Merlo M, Pinamonti B, editors. Dilated Cardiomyopathy: From Genetics to Clinical Management [Internet] //. Cham (CH): Springer. -2019. -Chapter 9.
  102. Katzmann JL, Schlattmann P, Rigopoulos AG, et al Meta-analysis on the immunohistological detection of inflammatory cardiomyopathy in endomyocardial biopsies // Heart Fail Rev. -2020 Mar. -Vol.25(2). -P. 277-294. doi: 10.1007/s10741-019-09835-9
  103. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria // Circulation. -2006 Jan 31. -Vol.113(4). -P. 593-5. doi.org/10.1161/CIRCULATIONAHA.105.589663
  104. Cooper LT, Baughman KL, Feldman AM, et al American Heart Association; American College of Cardiology; European Society of Cardiology; Heart Failure Society of America; Heart Failure Association of the European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology // J Am Coll Cardiol. -2007 Nov 6. -Vol.50(19). -P. 1914-31. doi: 10.1016/j.jacc.2007.09.008
  105. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults // J Am Coll Cardiol. -2003. -Vol.42. -P. 466-472. doi: 10.1016/s0735-1097(03)00648-x.
  106. Ponikowski P, Voors A, Anker S, et.al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC // Eur Heart J. -2016 Jul 14. -Vol.37(27). -P. 2129-2200. doi.org/10.1093/eurheartj/ehw128
  107. Ahmed H, VanderPluym C. Medical management of pediatric heart failure // Cardiovasc Diagn Ther. -2021. -Vol.11(1). -P.323-335. doi: 10.21037/cdt-20-358
  108. Das BB. Current State of Pediatric Heart Failure // Children (Basel). -2018. -Vol.5(7). -P.88. doi: 10.3390/children5070088
  109. Masarone D, Valente F, Rubino M, Vastarella R, et.al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management // Pediatr Neonatol. -2017 Aug. -Vol. 58(4). -P. 303-312. doi: 10.1016/j.pedneo.2017.01.001
  110. Kirk R, Dipchand AI, Rosenthal DN, et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary // J Heart Lung Transplant. – 2014. -Vol.33. -P. 888-909. doi: 10.1016/j.healun.2014.06.002
  111. Rossano JW, Kim JJ, Decker JA, et al. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study // J Card Fail. -2012. -Vol.18. -P. 459-70. doi: 10.1016/j.cardfail.2012.03.001
  112. Chioncel O, Parissis J, Mebazaa A, Thiele H et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology // Eur J Heart Fail. -2020 Aug. -Vol.22(8). P. 1315-1341. doi: 10.1002/ejhf.1922
  113. Law YM, Lal AK, Chen S, Čiháková D et al. American Heart Association Pediatric Heart Failure and Transplantation Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Stroke Council. Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association // Circulation. -2021 Aug 10. -Vol.144(6). -e123-135. doi: 10.1161/CIR.0000000000001001
  114. Caviedes B P, et al. Dilated cardiomyopathy and severe heart failure. An update for pediatricians // Arch Argent Pediatr. - 2018 Jun 1. -Vol.116(3). -e421-428. doi: 10.5546/aap.2018.eng.e421.
  115. Miller TL, Neri D, Extein J, Somarriba G, Strickman-Stein N. Nutrition in Pediatric Cardiomyopathy // Prog Pediatr Cardiol. -2007. -Vol. 24(1). P. 59-71. doi: 10.1016/j.ppedcard.2007.08.007
  116. Лазарев В.В. Особенности детского организма / В.В. Лазарев // Интенсивная терапия: Национальное руководство / под ред. Б.Р. Гельфанда, А.И. Салтанова. -Москва: ГЭОТАРМедиа, 2009. -С. 490-505
  117. Matsumori A, Igata H, Ono K, Iwasaki A, Miyamoto T, Nishio R, Sasayama S. High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity // Jpn Circ J. -1999. -Vol.63. -P. 934–940.2 doi: 10.1253/jcj.63.934
  118. СавенковаМ.C., ВашураЛ.В., АбдулаевА.К., АнджельА.Е., БалакиреваГ.М., РумянцеваИ.Г., КузнецоваЕ.С. Значениегерпесвирусныхинфекцийудетей // Педиатрия. Журнал им. Г. Н. Сперанского. -2016. -№2.
  119. Pinninti SG, Kimberlin DW. Preventing herpes simplex virus in the newborn // Clin Perinatol. -2014 Dec. -Vol.41(4). -P. 945-55. doi: 10.1016/j.clp.2014.08.012.
  120. Harris JB, Holmes AP. Neonatal Herpes Simplex Viral Infections and Acyclovir: An Update // J Pediatr Pharmacol Ther. -2017. -Vol.22(2). -P. 88-93. doi: 10.5863/1551-6776-22.2.88.
  121. Lim Y, Lyall H. Congenital cytomegalovirus - who, when, what-with and why to treat? // J Infect. -2017 Jun. -74 Suppl 1. -S89-S94. doi: 10.1016/S0163-4453(17)30197-4
  122. Luck SE, Wieringa JW, Blázquez-Gamero D, Henneke P, et al. ACTM; ESPID Congenital CMV Group Meeting, Leipzig 2015. Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management // Pediatr Infect Dis J. -2017 Dec. -Vol.36(12). -P. 1205-1213. doi: 10.1097/INF.0000000000001763.
  123. Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DWet al.. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy // Lancet Infect Dis. -2017 Jun. -Vol.17(6). -e177-188. doi: 10.1016/S1473-3099(17)30143-3
  124. Maisch B, Pankuweit S. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy // Herz. -2012. -Vol.37. -P. 644–656. doi: 10.1007/s00059-012-3679-9.
  125. Понежева Ж.Б., Гришаева А.А., Попова Т.И. Клинические формы вирусной инфекции Эпштейна — Барр // РМЖ. -2019. -№10. -C.36-41.
  126. Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen RJ, van Paassen P, Tervaert JW, Wolffs P, Goossens VJ, Bruggeman C, Waltenberger J, Crijns HJ, Heymans S. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load //Antivir Ther. -2010. -Vol.15 (2). -P. 193–201. doi: 10.3851/IMP1516
  127. Kuhl, U., Lassner, D., von Schlippenbach, J., Poller, W.& Schultheiss, H. P. Interferon- beta improves survival in enterovirus- associated cardiomyopathy // J. Am.Coll. Cardiol. -2012. – Vol.60. -P. 1295–1296. doi: 10.1016/j.jacc.2012.06.026
  128. Schultheiss, H. P. et al. Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon- β treatment in patients with chronic viral cardiomyopathy // Clin. Res. Cardiol. -2016. -Vol. 105. -P. 763–773. doi: 10.1007/s00392-016-0986-9
  129. Costanzo-Nordin MR, Reap EA, O’Connell JB, Robinson JA, Scanlon PJ. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis // J Am Coll Cardiol. -1985. -Vol.6. -P. 1078–1082. doi: 10.1016/s0735-1097(85)80312-0
  130. Khatib R, Reyes MP, Smith F, Khatib G, Rezkalla S. Enhancement of coxsackievirus B4 virulence by indomethacin // J Lab Clin Med. -1990. -Vol.116. -P. 662–670.
  131. Lin MS., Tseng YH., Chen MY. et al. In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy // BMC Cardiovasc Disorders 19. -2019.
  132. Prasad AN, Chaudhary S. Intravenous immunoglobulin in children with acute myocarditis and/or early dilated cardiomyopathy // Indian Pediatr. -2014. -Vol.51(7). -P. 583–4. doi: 10.1007/s13312-014-0456-2
  133. Kim HS, Sohn S, Park JY, Seo JW. Fulminant myocarditis successfully treated with high dose immunoglobulin // Int J Cardiol. -2004. -Vol.96(3). -P. 485–6. doi: 10.1016/j.ijcard.2003.05.037
  134. Tsai YG, Ou TY, Wang CC, Tsai MC et al.. Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: report of one case // Acta Paediatr Taiwan. -2001. -Vol.42(5). -P. 311–3.
  135. Xin Huang, Yufei Sun, Guanhua Su, Yu Li, Xinxin Shuai, Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults // International Heart Journal. -2019. -Vol. 60 (2). -P. 359-365. doi: 10.1536/ihj.18-299
  136. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Gamma-globulin treatment of acute myocarditis in the pediatric population // Circulation. -1994. -Vol.89. -P. 252–257.
  137. Maisch B, Hufnagel G, Kölsch S, Funck R, Richter A, Rupp H, Herzum M, Pankuweit S. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins // Herz. -2004 Sep. -Vol.29(6). -P. 624-36.
  138. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial // J Am Coll Cardiol. -1991. -Vol.17(2). -P. 458–60. doi: 10.1016/s0735-1097(10)80115-9
  139. Kleinert S, Weintraub RG, Wilkinson JL, Chow CW. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression // J Heart Lung Transplant. -1997. -Vol.16(12). -P. 1248–54.
  140. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME. Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators // N Engl J Med. -1995. -Vol.333(5). -P. 269–75. doi: 10.1056/NEJM199508033330501
  141. Camargo PR, Snitcowsky R, da Luz PL, Mazzieri R, Higuchi ML, Rati M, Stolf N, Ebaid M, Pileggi F. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis // Pediatr Cardiol. -1995. -Vol.16(2). -P. 61–8. doi: 10.1007/BF00796819
  142. Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study // Cardiol Young. -2010 Oct. -Vol.20(5). -P. 509-15.
  143. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review // Arch Dis Child. -2004. -Vol.89(6). -P. 580–4. doi: 10.1136/adc.2003.034686
  144. Lu C, Qin F, Yan Y, Liu T, Li J, Chen H. Immunosuppressive treatment for myocarditis: a meta-analysis of randomized controlled trials // J Cardiovasc Med (Hagerstown). -2016. -Vol.17(8). -P. 631.
  145. Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis // Cochrane Database Syst Rev.- 2013. -Vol.2013 (10). doi: 10.1002/14651858.CD004471.pub3
  146. Herda L.R. et al. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy//Am. Heart J. -2010. -Vol.159(5). -P. 809-816. doi: 10.1016/j.ahj.2010.01.012
  147. Bulut D. et al. Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy // Clin. Res. Cardiol. Off. J. Ger. Card. Soc. -2010. -Vol.99(10). -P. 633-638. doi: 10.1007/s00392-010-0162-6
  148. Maron BJ. et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology // Circulation. -2015. -Vol.132 (22). -e.273-80. doi: 10.1161/CIR.0000000000000239
  149. Bozkurt, B. et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association // Circulation. -2016. -Vol.134. -e579–646. doi.org/10.1161/CIR.0000000000000455
  150. Ogunbayo GO, Elayi SC, Ha LD, Olorunfemi O, Elbadawi A, Saheed D,Sorrell VL. Outcomes of heart block in myocarditis: a review of 31,760 patients // Heart Lung Circ. -2019. -Vol. 28. -P. 272–276. doi: 10.1016/j.hlc.2017.12.005
  151. Gagliardi MG, Fierabracci A, Pilati M, et al. The impact of specific viruses on clinical outcome in children presenting with acute heart failure // Int J Mol Sci. – 2016. -Vol. 17(4). -P. 1–10. doi: 10.3390/ijms17040486
  152. Kirk R, Naftel D, Hoffman TM, et al. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study // J Heart Lung Transpl. – 2009 Dec. -Vol.28 (12). -P. 1322-8. doi: 10.1016/j.healun.2009.05.027
  153. Pietra BA, Kantor PF, Bartlett HL, et al. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy // Circulation. -2012 Aug 28. -Vol. 126 (9). -P. 1079-86. doi: 10.1161/CIRCULATIONAHA.110.011999
  154. World Health Organization. International Classification of Functioning, Disability and Health: ICF. Geneva: WHO, 2001. — P. 3-29.
  155. Piepoli MF, Conraads V, Corra` U. et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation // Eur. J. Heart. Fail. – 2011. – Nо. 13. – Р. 347–357.
  156. Tikkanen AU, Berry E, LeCount E et al. Rehabilitation in Pediatric Heart Failure and Heart Transplant. Front Pediatr. - 2021 May 19. 9:674156. doi: 10.3389/fped.2021.674156. PMCID: PMC8170027.
  157. Paridon SM, Alpert BS, Alpert BS. Clinical stress testing in the pediatric age group: a statement from the American Heart Association council on cardiovascular disease in the young, committee on atherosclerosis, hypertension, and obesity in youth. Circulation. -2006. - Vol. 113(15). P. 1905–1920.
  158. McBride MG, Burstein DS, Edelson JB, Paridon SM. Cardiopulmonary Rehabilitation in Pediatric Patients With Congenital and Acquired Heart Disease. J Cardiopulm Rehabil Prev. - 2020. - Vol. 40(6). - P. 370-377. doi: 10.1097/HCR.0000000000000560.
  159. Davies E.J. et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis // Eur. J. Heart Fail. -2010. -Vol.12(7). -P. 706–715. doi: 10.1093/eurjhf/hfq056
  160. Ribeiro J.P., Chiappa G.R., Callegaro C.C. The contribution of inspiratory muscles function to exercise limitation in heart failure: pathophysiological mechanisms // Rev. Bras. Fisioter. Sao Carlos Sao Paulo Braz. -2012. -Vol.16(4). -P. 261–267. doi.org/10.1590/S1413-35552012005000034
  161. Pandey A. et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials // Circ. Heart Fail. -2015 Jan. -Vol. 8 (1). – P. 33–40. doi: 10.1161/CIRCHEARTFAILURE.114.001615
  162. Батышева Т.Т., Медико-психологическая помощь детям с нарушением психического развития в системе комплексной реабилитации // Методические рекомендации, г. Москва. -2018. -C. 5-568.
  163. Таточенко В.К., Н.А. Озерецковский. Иммунопрофилактика-2020: справочник, 13-е издание, расширенное // Москва: Боргес. -2020. – C. 16 — 23.
  164. Басаргина Е.Н. Сердечная недостаточность. В кн.: М.А. Школьникова, Е.И. Алексеева, ред. Клинические рекомендации по детской кардиологии и ревматологии // М.: «ООО М-Арт». -2011. -C. 242–276.
  165. Басаргина Е.Н., Миокардит у детей: трудности диагностики и лечения // журнал «Педиатрия». -г. Москва -2015. – N.94(2). - С.158- 160.
  166. Mirabel M. et al. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support // Crit. Care Med. -2011. -Vol. 39 (5). -P. 1029–1035. doi: 10.1097/CCM.0b013e31820ead45
  167. Hsu K.-H. et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center’s experience // Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. – 2011. -Vol. 40 (3). - P. 682–688. doi: 10.1016/j.ejcts.2010.12.050

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*